TWiV 721: COVID-19 clinical update #50 with Dr. Daniel Griffin

February 20, 2021

In COVID-19 clinical update #50, Daniel Griffin discusses CDC guidance on school opening, decreased viral load after vaccination, randomized clinical trial of vitamin D treatment, a study of zinc plus vitamin C, anticoagulation therapy effect on mortality, and multi system inflammatory phase in children.

Hosts: Daniel Griffin and Vincent Racaniello

Click arrow to play
Download TWiV 721 (18 MB .mp3, 30 min)
Subscribe (free): iTunesGoogle PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv

Leave a Reply to Steve Kennedy Cancel Reply

Your email address will not be published. Required fields are marked *

3 comments on “TWiV 721: COVID-19 clinical update #50 with Dr. Daniel Griffin

  1. Steve Kennedy Feb 20, 2021

    Are you aware of the NIH study showing that nano silver colloid is 100% effective in killing Covid-19? Here is the link:
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486059/
    Given the fear of many about the effects of the mRNA vaccines after seeing many elderly people die from receiving the vaccine, why is silver colloid never offered as a safe alternative? My wife and I have been taking one TBS/day of 10ppm nano (10nm) silver colloid for seven years and have never had a cold, flu or any virus, bacterial infection, nothing! Please explain why this information has never been made known by you or anyone in virology?

  2. Will Grad Feb 20, 2021

    Hi. Really enjoy your podcast and value your commentary. Have shared your podcast with many colleagues and look forward every week to what you have to say. However, one thing confuses me, Daniel – Your seeming unwavering support for monoclonals. Listening to a variety of other credible sources, it seems to me that the data just is not as certain as you seem to feel it is. Here are a few counter opinions, 2 from emergency medicine specialists and one from an Intensivist. All these sources are credible ones, from individuals, like yourself, committed to providing the best info to their colleagues and care to their patients What are they not seeing that you are?

    Thank you.

    https://rebelem.com/blaze-1-final-publication-monoclonal-antibody-cocktail-part-ii/

    https://brief19.com/2021/01/26/brief/monoclonal-antibodies-yet-to-show-important-clinical-benefit-in-patients-with-covid-19-a-review-of-what-we-know-including-the-latest-clinical-trial-data

    https://emcrit.org/pulmcrit/convalescent-plasma/